本文選題：宮頸癌　切入點(diǎn)：EFEMP　出處：《中華腫瘤防治雜志》2015年21期

【摘要】：目的前期研究已證實(shí)EFEMP1能促進(jìn)宮頸癌微血管增生,本研究旨在進(jìn)一步探討EFEMP1促進(jìn)宮頸癌微血管生成的分子機(jī)制。方法利用Pierce CO-IP試劑盒檢測(cè)宮頸癌細(xì)胞中EFEMP1蛋白和表皮生長(zhǎng)因子受體(epidermal growth factor receptor,EGFR)的相互作用,蛋白質(zhì)印跡法檢測(cè)蛋白表達(dá)。利用MTT實(shí)驗(yàn)檢測(cè)內(nèi)皮細(xì)胞增殖活力,Transwell小室法檢測(cè)內(nèi)皮細(xì)胞遷移能力,Matrigel膠管腔形成能力實(shí)驗(yàn)檢測(cè)內(nèi)皮管腔形成能力。構(gòu)建慢病毒干擾顆粒干擾宮頸癌細(xì)胞Jagged1表達(dá)。利用免疫組化MaxVisonTM法檢測(cè)組織蛋白表達(dá),內(nèi)皮CD34組化標(biāo)記結(jié)合Weinner計(jì)數(shù)法檢測(cè)組織中微血管密度(microvsacular density,MVD)。皮下接種Hela-EFEMP1+細(xì)胞構(gòu)建高表達(dá)EFEMP1的裸鼠荷瘤模型。結(jié)果 p-EGFR和p-MAPK在EFEMP1處理組Hela細(xì)胞的表達(dá)水平(2.35±0.41和2.56±0.44)分別高于對(duì)照組(0.20±0.001,P=0.001;0.64±0.020,P=0.001)和PD153035與EFEMP1聯(lián)合處理組(1.25±0.33,P=0.004;1.46±0.24,P=0.001)。CO-IP結(jié)果顯示,Hela細(xì)胞中EFEMP1與EGFR相互作用。處理組內(nèi)皮細(xì)胞24h活力(1.78±0.048)、遷移能力(71.7±4.91)和管腔形成能力(19.7±1.75)分別高于對(duì)照組(1.38±0.046,P=0.001;30±3.46,P=0.002 3;8.7±1.84,P=0.001 8)和聯(lián)合處理組(1.51±0.072,P=0.004;37.6±4.98,P=0.008 3;12.6±1.48,P=0.009 3)。處理組癌細(xì)胞中p-MAPK、血管內(nèi)皮生長(zhǎng)因子(vascular endothelia growth factor,VEGF)和Jagged1的表達(dá)水平(0.96±0.05,1.25±0.031,0.82±0.036)分別高于對(duì)照組(0.16±0.006,P=0.028;0.54±0.047,P=0.013;0.42±0.017,P=0.026)和U0126與EFEMP1聯(lián)合處理組(0.56±0.022,P=0.042;0.29±0.016,P=0.008;0.38±0.037,P=0.024)。EFEMP1處理Hela-Jagged1siRNA細(xì)胞后上清液作用下的內(nèi)皮管腔形成能力(14±1.58,P=0.006)和γ-SI與處理組正常癌細(xì)胞上清液聯(lián)合作用的內(nèi)皮細(xì)胞管腔形成能力(12.6±1.33,P=0.008),分別低于處理組癌細(xì)胞上清液作用下的內(nèi)皮細(xì)胞(19.7±0.89)。宮頸癌組織中,EFEMP1表達(dá)分別與p-MAPK和Jagged1表達(dá)正相關(guān),p-MAPK表達(dá)與Jagged1表達(dá)正相關(guān),且p-MAPK和Jagged1的表達(dá)分別與宮頸癌MVD呈正相關(guān)。動(dòng)物實(shí)驗(yàn)結(jié)果顯示,LV-JAG1-RNAi慢病毒處理組腫瘤平均體積和質(zhì)量〔(0.160±0.007)cm3;(0.43±0.043)g〕分別明顯小于對(duì)照組〔(0.25±0.015)cm3,P=0.001;(0.65±0.027)g,P=0.002〕。此外,處理組平均MVD(5.0±1.23)也低于對(duì)照組(8.7±1.15,P=0.014)。結(jié)論 EFEMP1促進(jìn)宮頸癌微血管生成的分子機(jī)制是通過(guò)與EGFR相互作用,激活MAPK-VEGF/Jagged1信號(hào)通路,上調(diào)宮頸癌VEGF和Jagged1的表達(dá)而旁分泌促進(jìn)內(nèi)皮血管生成。
[Abstract]:Objective to investigate the molecular mechanism of EFEMP1 promoting microangiogenesis in cervical cancer.Methods the interaction of EFEMP1 protein and epidermal growth factor receptor (EGFR) in cervical cancer cells was detected by Pierce CO-IP kit, and protein expression was detected by Western blot.MTT assay was used to detect endothelial cell proliferation activity and transwell chamber method was used to detect the migration ability of endothelial cells.Lentivirus interference particles were constructed to interfere with the expression of Jagged1 in cervical cancer cells.The expression of tissue protein was detected by immunohistochemical MaxVisonTM method, and the microvascular density (MVD) was detected by CD34 histochemistry and Weinner counting.Hela-EFEMP1 cells were inoculated subcutaneously to construct a tumor-bearing model of nude mice with high expression of EFEMP1.澶勭悊緇勭檶緇嗚優(yōu)涓璸-MAPK,琛，

本文編號(hào)：1730747